发明公开
EP2956153A1 TREATMENT OF EVOLVING BACTERIAL RESISTANCE DISEASES INCLUDING KLEBSIELLA PNEUMONIAE WITH LIPOSOMALLY FORMULATED GLUTATHIONE
审中-公开
克雷伯菌肺炎的治疗介导的疾病不断发展的抗菌性使用脂质体制定谷胱甘肽
- 专利标题： TREATMENT OF EVOLVING BACTERIAL RESISTANCE DISEASES INCLUDING KLEBSIELLA PNEUMONIAE WITH LIPOSOMALLY FORMULATED GLUTATHIONE
- 专利标题（中）： 克雷伯菌肺炎的治疗介导的疾病不断发展的抗菌性使用脂质体制定谷胱甘肽
-
申请号： EP13875036.9申请日： 2013-03-15
-
公开(公告)号： EP2956153A1公开(公告)日： 2015-12-23
- 发明人: GUILFORD, Frederick Timothy
- 申请人： Your Energy Systems, LLC
- 申请人地址： 555 Bryant St. No.305 Palo Alto, CA 94301 US
- 专利权人： Your Energy Systems, LLC
- 当前专利权人： Your Energy Systems, LLC
- 当前专利权人地址： 555 Bryant St. No.305 Palo Alto, CA 94301 US
- 代理机构： Isarpatent
- 优先权： US201361765379P 20130215; US201361767464P 20130221
- 国际公布： WO2014126594 20140821
- 主分类号： A61K38/06
- IPC分类号： A61K38/06 ; A61K31/43 ; A61K31/59 ; A61K9/127 ; A61P31/00 ; A61P31/04 ; G01N33/50
摘要：
The composition of the invention, liposomal glutathione, has been recently shown to have utility for having an antibiotic like effect on Klebsiella pneumonia cultures in vitro, and in vivo as demonstrated by efficacy in reducing by large multiples the presence of cultures of Klebsiella in rats in animal tests. Further, because the liposomal glutathione bolsters body defenses as well as appearing to have direct killing action, the propensity to create more and more resistant strains to antibiotic treatment is downgraded.
信息查询
IPC分类:
